Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

High Concentration of Tumor Marker Cancer Antigen CA15-3 in Breast CancerPatients after Surgery

Adam MA Osman, Mohamed E Hamid, Ayda H Satti and Ibtisam A Goreish

Background: Cancer antigen15-3 (CA15-3) is the most common tumor marker in breast cancer patients. The aim of the study analysis was to investigate the correlation, if there is any, of the levels of CA15-3 in patients with breast cancer and healthy females and to evaluate the efficacy of cancer associated antigen 15-3 (CA15-3) in monitoring breast cancer.
Methods: Clinical assessment was carried out in 40 serum samples. Female patient (n=20) were histologically verified of having breast cancer after chemical treatment and surgery. Healthy females subjects (n=20) with no history of breast cancer were included as controls. Enzyme linked immunosorbent assays was used for the quantitative determination of the cancer associate antigen.
Result: Elevation of CA15-3 levels was found associated with breast cancer patients. The serological levels were found around 75.04 ± SD/ mL (P=0.001), whereas the level among the control group was 13.99 ± SD/ mL).
Conclusion: CA15-3 concentration levels were found elevated in breast cancer patients with significant level demonstrating its diagnostic routine use.